MICROLEARNING Optimal Risk Stratification and Combination Therapy: Improving Outcomes in PAH
CE Information: 0.25 CNE Credit and AAPA Category 1 credit
Available Until: February 20, 2027
Completion Time: 15 minutes
Specialties
Pulmonology, Cardiology
Target Audience
This initiative is designed to address the professional needs of specialty NPs and PAs involved in the care of patients with pulmonary hypertension.
Pulmonary arterial hypertension (PAH) is a rare, progressive subtype of pulmonary hypertension characterized by narrowing and remodeling of the small pulmonary arteries, which leads to elevated pulmonary vascular resistance, increased pulmonary arterial pressures, and eventual right ventricular failure. Despite advances in targeted therapies, PAH remains associated with substantial morbidity, reduced functional capacity, impaired quality of life, and increased mortality, with historical survival measured in only a few years without effective treatment.
After participating in this education, learners will be able to:
Jennifer Persio, MSN, APRN, ACNPC-AG
Senior Nurse Practitioner
Yale Pulmonary Vascular Disease Program
New Haven, Connecticut
Una Hopkins, DNP
Terry Glauser, MD, MA
Chelsey Goins, PhD
Albert Einstein College of Medicine-Montefiore Medical Center designates this activity for 0.25 nursing contact hours. Nurses should claim only credit commensurate with the extent of their participation in the activity.
Albert Einstein College of Medicine-Montefiore Medical Center has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Supported by an education grant from Merck Sharp & Dohme LLC.
The “Policy on Identification, Mitigation, and Disclosure of Relevant Financial Relationships” at Albert Einstein College of Medicine-Montefiore Medical Center mandates that all individuals, including faculty, who have control over content in CME/CE activities, must disclose any relevant financial relationships with ineligible companies*, or the absence of such relationships, from the past 24 months to the audience. Any individual in control of content who refuses to disclose, or their disclosed relationships prove to create a conflict of interest will be recused.
All financial relationships of individual(s) in a position to control the content of this CME/CE activity has been identified and mitigated prior to this educational activity.
*The ACCME defines an ineligible company as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Jennifer Persio, MSN, APRN, ACNPC-AG, does not have any relevant financial relationships with ACCME-defined ineligible companies during the past 24 months.
Chelsey Goins, PhD, does not have any relevant financial relationships with ACCME-defined ineligible companies during the past 24 months.
Una Hopkins, DNP, does not have any relevant financial relationships with ACCME-defined ineligible companies during the past 24 months.
Terry Glauser, MD, MA, does not have any relevant financial relationships with ACCME-defined ineligible companies during the past 24 months.
